Back to RXRX
VANGUARD GROUP INC RXRX Position History
Recursion Pharmaceuticals, Inc.
Quarters held
20
Latest value
$1.3M
Q4 2025
Peak value
$178.6M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $576K |
| Q1 2025 | $167.5M |
| Q1 2025 | $1.3M |
| Q1 2025 | $308K |
| Q1 2025 | $1.2M |
| Q2 2025 | $601K |
| Q2 2025 | $178.6M |
| Q2 2025 | $1.7M |
| Q2 2025 | $351K |
| Q2 2025 | $1.3M |
| Q3 2025 | $13.3M |
| Q3 2025 | $338K |
| Q3 2025 | $892K |
| Q3 2025 | $1.3M |
| Q3 2025 | $178.3M |
| Q4 2025 | $846K |
| Q4 2025 | $176.5M |
| Q4 2025 | $13.9M |
| Q4 2025 | $404K |
| Q4 2025 | $1.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $1.3M | 315.1K | — | — |
| Q4 2025 | $404K | 98.8K | — | — |
| Q4 2025 | $13.9M | 3.40M | — | — |
| Q4 2025 | $176.5M | 43.17M | — | — |
| Q4 2025 | $846K | 206.8K | — | — |
| Q3 2025 | $178.3M | 36.53M | — | — |
| Q3 2025 | $1.3M | 271.2K | — | — |
| Q3 2025 | $892K | 182.8K | — | — |
| Q3 2025 | $338K | 69.3K | — | — |
| Q3 2025 | $13.3M | 2.73M | — | — |
| Q2 2025 | $1.3M | 250.3K | — | — |
| Q2 2025 | $351K | 69.3K | — | — |
| Q2 2025 | $1.7M | 330.4K | — | — |
| Q2 2025 | $178.6M | 35.30M | — | — |
| Q2 2025 | $601K | 118.7K | — | — |
| Q1 2025 | $1.2M | 218.4K | — | — |
| Q1 2025 | $308K | 58.1K | — | — |
| Q1 2025 | $1.3M | 239.0K | — | — |
| Q1 2025 | $167.5M | 31.66M | — | — |
| Q1 2025 | $576K | 108.9K | — | — |